265 related articles for article (PubMed ID: 29924727)
21. Acid sphingomyelinase - a regulator of canonical transient receptor potential channel 6 (TRPC6) activity.
Zeitler S; Ye L; Andreyeva A; Schumacher F; Monti J; Nürnberg B; Nowak G; Kleuser B; Reichel M; Fejtová A; Kornhuber J; Rhein C; Friedland K
J Neurochem; 2019 Sep; 150(6):678-690. PubMed ID: 31310676
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
23. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.
Dumitru CA; Gulbins E
Oncogene; 2006 Sep; 25(41):5612-25. PubMed ID: 16636669
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipid metabolism and neutral sphingomyelinases.
Airola MV; Hannun YA
Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
[TBL] [Abstract][Full Text] [Related]
25. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.
Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH; Nikolova-Karakashian M
J Biol Chem; 2009 Mar; 284(13):8359-68. PubMed ID: 19074137
[TBL] [Abstract][Full Text] [Related]
26. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids.
Lepple-Wienhues A; Belka C; Laun T; Jekle A; Walter B; Wieland U; Welz M; Heil L; Kun J; Busch G; Weller M; Bamberg M; Gulbins E; Lang F
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13795-800. PubMed ID: 10570152
[TBL] [Abstract][Full Text] [Related]
28. TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx.
Church LD; Hessler G; Goodall JE; Rider DA; Workman CJ; Vignali DA; Bacon PA; Gulbins E; Young SP
J Leukoc Biol; 2005 Jul; 78(1):266-78. PubMed ID: 15817701
[TBL] [Abstract][Full Text] [Related]
29. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells.
Medler TR; Petrusca DN; Lee PJ; Hubbard WC; Berdyshev EV; Skirball J; Kamocki K; Schuchman E; Tuder RM; Petrache I
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):639-46. PubMed ID: 18192502
[TBL] [Abstract][Full Text] [Related]
30. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death.
Mullen TD; Obeid LM
Anticancer Agents Med Chem; 2012 May; 12(4):340-63. PubMed ID: 21707511
[TBL] [Abstract][Full Text] [Related]
31. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
32. The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke Therapies.
Mohamud Yusuf A; Hagemann N; Hermann DM
Neurosignals; 2019; 27(S1):32-43. PubMed ID: 31778304
[TBL] [Abstract][Full Text] [Related]
33. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
Abusukhun M; Winkler MS; Pöhlmann S; Moerer O; Meissner K; Tampe B; Hofmann-Winkler H; Bauer M; Gräler MH; Claus RA
Front Immunol; 2021; 12():784989. PubMed ID: 34987511
[TBL] [Abstract][Full Text] [Related]
34. [Ceramide-centered sphingolipid metabolism].
Kitatani K; Asano S; Hashimoto M; Taniguchi M; Okazaki T
Seikagaku; 2011 Jun; 83(6):495-505. PubMed ID: 21800680
[No Abstract] [Full Text] [Related]
35. The Forebrain-Specific Overexpression of Acid Sphingomyelinase Induces Depressive-Like Symptoms in Mice.
Zoicas I; Schumacher F; Kleuser B; Reichel M; Gulbins E; Fejtova A; Kornhuber J; Rhein C
Cells; 2020 May; 9(5):. PubMed ID: 32443534
[TBL] [Abstract][Full Text] [Related]
36. Infections with human rhinovirus induce the formation of distinct functional membrane domains.
Dreschers S; Franz P; Dumitru C; Wilker B; Jahnke K; Gulbins E
Cell Physiol Biochem; 2007; 20(1-4):241-54. PubMed ID: 17595532
[TBL] [Abstract][Full Text] [Related]
37. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?
Tomiuk S; Hofmann K; Nix M; Zumbansen M; Stoffel W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3638-43. PubMed ID: 9520418
[TBL] [Abstract][Full Text] [Related]
38. The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice.
Okuro RT; Machado MN; Casquilho NV; Jardim-Neto A; Roncally-Carvalho A; Atella GC; Zin WA
Pulm Pharmacol Ther; 2018 Jun; 50():100-110. PubMed ID: 29702255
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
Brunkhorst R; Friedlaender F; Ferreirós N; Schwalm S; Koch A; Grammatikos G; Toennes S; Foerch C; Pfeilschifter J; Pfeilschifter W
Neural Plast; 2015; 2015():503079. PubMed ID: 26605090
[TBL] [Abstract][Full Text] [Related]
40. Involvement of sphingolipids in apoptin-induced cell killing.
Liu X; Zeidan YH; Elojeimy S; Holman DH; El-Zawahry AM; Guo GW; Bielawska A; Bielawski J; Szulc Z; Rubinchik S; Dong JY; Keane TE; Tavassoli M; Hannun YA; Norris JS
Mol Ther; 2006 Nov; 14(5):627-36. PubMed ID: 16926120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
